PT  - JOURNAL ARTICLE
AU  - Rojiemiahd K Edjoc
AU  - Robert D Reid
AU  - Mukul Sharma
AU  - Louise Balfour
AU  - Michael Procino
TI  - Correlates of former smoking in patients with cerebrovascular disease: a cross-sectional study
AID  - 10.1136/bmjopen-2014-005753
DP  - 2015 Jan 01
TA  - BMJ Open
PG  - e005753
VI  - 5
IP  - 1
4099  - http://bmjopen.bmj.com/content/5/1/e005753.short
4100  - http://bmjopen.bmj.com/content/5/1/e005753.full
SO  - BMJ Open2015 Jan 01; 5
AB  - Objective To identify multilevel correlates of former smoking in patients with cerebrovascular disease.Design Secondary data analysis of the Canadian Community Health Survey.Methods We used data from the 2007–2008 Canadian Community Health Survey (CCHS). Smoking status (former smoking vs smoker) was described by multilevel correlates of former smoking. A multilevel approach for variable selection for this study was used to understand how multiple levels in society can have an impact on former smoking. The study sample was selected from those respondents of the CCHS that reported they suffered from stroke symptoms. Logistic regression was used to predict former smoking in patients with cerebrovascular disease while controlling for multilevel confounders. Proportions were weighted to reflect the Canadian population.Results There were 172 355 respondents who reported to suffer from stroke. From this sample, 36.5% were smokers and 63.5% were former smokers. Age groups 55–69 and 70–80 and higher education (secondary education +) were positively related to former smoking. Household and vehicle smoking restrictions significantly predicted former smoking. Counselling advice from a physician and having access to a general practitioner were correlates of former smoking. Finally, the use of buproprion was positively related to former smoking.Conclusions There are multilevel correlates of former smoking in smokers with reported stroke symptoms. These correlates include older age groups, higher education, household and vehicle smoking restrictions, pharmacotherapy use (bupropion), access to a general practitioner and counselling advice from a physician.